XML 83 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE CAPITAL (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 29, 2018
Jul. 20, 2018
Dec. 31, 2017
Feb. 26, 2015
Feb. 13, 2015
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2017
Mar. 31, 2018
Mar. 31, 2017
Jun. 12, 2018
Nov. 06, 2017
Share-based Compensation           $ 439,328 $ 762,208 $ 1,034,740   $ 1,013,256 $ 1,540,580 $ 1,001,950    
Proceeds from Warrant Exercises               0   1,125,038 1,125,038 40,195    
Debt Conversion, Original Debt, Amount     $ 50,000               9,171,604      
Debt Conversion, Original Debt to be Converted, Amount                 $ 1,220,629   $ 1,220,629      
Debt Conversion, Converted Instrument, Shares to be Issued                 263,639   263,639      
Debt Conversion, Converted Instrument, Value of Shares to be Issued                 $ 2,470,622   $ 2,470,622      
Loss on Mark to Market Reevaluation               $ (2,048,697)   $ 0 376,674 $ 0    
Market Value of Shares                 $ 2,847,296   $ 2,847,296      
Stock Issued During Period, Shares, Exchangeable Shares Excercised               21,572     24,250 13,938    
Common Stock, Shares Authorized         200,000,000 500,000,000   500,000,000 250,000,000   250,000,000 150,000,000 500,000,000 250,000,000
Adjustments to Additional Paid in Capital, Stock Option and Warrant Reclassification               $ 1,173,534 $ (2,845,557)   $ (2,845,557)      
Preferred Stock, Voting Rights       the Company issued one share of the Special Voting Preferred Stock, par value $0.001 per share                    
Stockholders' Equity, Reverse Stock Split         the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014.                  
Gain Loss On Mark To Market Reevaluation                     $ 376,674      
Shares issued on conversion of loans (in shares)   683,395           263,639     985,370      
Stock Issued During Period, Value, Conversion of Loans   $ 4,732,853           $ 2,470,622 $ 9,180,785   $ 9,180,785      
Common Shares [Member]                            
Stock Issued During Period, Shares, Issued for Services                       1,447    
Stock Issued During Period, Value, Issued for Services                       $ 59,500    
Share-based Compensation                       $ 43,562    
Stock Issued During Period, Shares, Conversion of Convertible Securities               947,034            
Subsequent Event [Member]                            
Stockholders' Equity, Reverse Stock Split the Company effected a reverse stock split and thereafter Bionik's common stock began trading on the OTCQB market on a one-for-one hundred and fifty (1:150) split adjusted basis.                          
Investor Relation And Consultine Services [Member]                            
Class of Warrant or Right, Exercise Price of Warrants or Rights                       $ 120.00    
Number Of Warrants Exercised                       1,747    
Convertible Debt [Member]                            
Stock Issued During Period, Shares, Conversion of Convertible Securities               683,395            
Convertible Debt [Member] | Common Shares [Member]                            
Stock Issued During Period, Shares, Conversion of Convertible Securities   263,639                        
Warrant [Member]                            
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 37.50   $ 37.50      
Stock Issued During Period, Shares, Warrants Exercised                     33,335      
Proceeds from Warrant Exercises                     $ 1,125,038